A Patient-Centred Approach to Optimizing Inhaled Therapy: Integrating Patient, Device, Drug and Disease Factors

Authors

  • George Philteos, MBBCh, MSc, FRCPC, D. ABSM

Abstract

Inhaled medications are crucial for the management of respiratory conditions such as chronic obstructive pulmonary disease and asthma, although their efficacy is contingent upon selecting the most appropriate inhaler and medication for each patient. Consideration should be given to factors such as inhaler technique, patient preference, coordination, inspiratory flow, small airway disease, and medication-related side effects. A patient-centred approach can maximize the benefits of inhaled therapy while minimizing potential risks. 

Author Biography

George Philteos, MBBCh, MSc, FRCPC, D. ABSM

Dr. George Philteos is a respirologist and sleep specialist at Lakeridge Health and Durham Institute of Respirology. He is the principal investigator for Dynamic Drug Advancement Clinical Research Center and his research interests spread from severe asthma, COPD, Chronic cough, to ILD trials. His clinics operate in the Durham Respiratory and Sleep Center, the Ellesmere Sleep Center and Sleep Wake Sleep Center. He has contributed to the development and presenting of CME activities, chairing respirology journal clubs and the development of guidelines.

References

Downloads

Published

2026-10-21

How to Cite

A Patient-Centred Approach to Optimizing Inhaled Therapy: Integrating Patient, Device, Drug and Disease Factors. (2026). Canadian Respirology Today, 2(1), 12-18. https://doi.org/10.58931/crt.2026.2122

Issue

Section

Articles

How to Cite

A Patient-Centred Approach to Optimizing Inhaled Therapy: Integrating Patient, Device, Drug and Disease Factors. (2026). Canadian Respirology Today, 2(1), 12-18. https://doi.org/10.58931/crt.2026.2122